AMGN
38
-6
JNJ
44
3
MA
57
2
SBUX
39
3
FMC
33
2
CFG
64
2
EW
39
2
IVZ
48
2
KMI
69
2
PLD
48
-5
SYK
68
4
ADSK
68
2
FE
52
3
CTSH
54
-2
PVH
57
5
MRO
40
-15
LEN
52
2
AAL
53
-4
EXC
56
2
TXT
52
4
AMGN
38
-6
JNJ
44
3
MA
57
2
SBUX
39
3
FMC
33
2
CFG
64
2
EW
39
2
IVZ
48
2
KMI
69
2
PLD
48
-5
SYK
68
4
ADSK
68
2
FE
52
3
CTSH
54
-2
PVH
57
5
MRO
40
-15
LEN
52
2
AAL
53
-4
EXC
56
2
TXT
52
4
Financhill
Back

Precision BioSciences Vs. Protagonist Therapeutics Industry Stock Comparison

Sell
4

DTIL
Precision BioSciences

Last Price:
7.35
Seasonality Move:
-6.51%
Sell
33

PTGX
Protagonist Therapeutics

Last Price:
45.18
Seasonality Move:
11.46%
Sell
4
Precision BioSciences (DTIL) is a Sell

Is Precision BioSciences a Buy, Sell or Hold?

  • The current Precision BioSciences [DTIL] share price is $6.50. The Score for DTIL is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • DTIL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.65. The Score for PTGX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DTIL Stock Price Chart

What is Precision BioSciences's stock price today?

  • The Precision BioSciences share price today is $6.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DTIL is experiencing selling pressure, which indicates risk of future bearish movement.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.

DTIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 19.42 Sell
Chaikin Money Flow: -161120 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.58 - 8.78) Sell
Bollinger Bands (100): (8.37 - 10.03) Sell

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 41.01 Sell
Chaikin Money Flow: -281616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.23 - 47.93) Sell
Bollinger Bands (100): (38.1 - 46.24) Sell

DTIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.49 Sell
20-day SMA: 8.04 Sell
50-day SMA: 8.77 Sell
200-day SMA: 10.64 Sell
8-day EMA: 7.36 Sell
20-day EMA: 7.92 Sell
50-day EMA: 8.57 Sell
200-day EMA: 10.91 Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.17 Buy
20-day SMA: 44.7 Sell
50-day SMA: 45.23 Sell
200-day SMA: 35.68 Buy
8-day EMA: 41.66 Sell
20-day EMA: 43.5 Sell
50-day EMA: 43.92 Sell
200-day EMA: 36.78 Buy

Precision BioSciences Earnings Growth & DTIL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.23 per share, and a decrease next year of $9.65 per share.

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.

Precision BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):